January 2021 - Wellthy Therapeutics

Monthly Archives: January 2021

Bridging the gap in care continuum with Medtech

Care Continuum

There was never a better time in then now to focus on medical innovation and tech-based healthcare delivery. Patients today are very evolved and are focused on proactive care and continuum of care. Patient -centricity is driving multiple tech-based innovations including the adoption of wearable technology. This has led to a sea of data waiting to help health practitioners in improving the delivery of healthcare and providing preemptive, proactive and precautionary care to people.

Can digital solutions really help medical adherence?

Medication adherence

The non-adherence of medical solutions and provisions by patients such as drugs, treatments or therapies is a cause of enormous concern in the healthcare world. This is leading to adverse health outcomes and increased cost of care. The healthcare workers require a steady partnership with patients to achieve a long-term therapeutic result. New age technology-driven digital solutions could really help the patients, workers, and providers to be in sync with each other, hence solving the issue to a large extent. While some of these solutions are already in use and trial, it requires a lot more innovation to make it cost-effective and a widely used feasible solution for the larger population.

Using digital technology to lower risks; the new age insurance

Digital Technology and Insurtech

Emerging technologies and innovations in digital technology are beginning to transform the insurance landscape as they enable new ways to measure, control, and price risk, engage with customers, reduce cost by improving efficiency and expand insurability. Consequently insures have enormous opportunities to bring in innovative insurance solutions and revamp their business models. Incumbent insurers and insurtech companies are now increasingly collaborating and aligning with the new digital commons to develop new business models and revenue streams by adopting a digital first, technology centric approach.

Digital health ecosystems to expand the boundaries of value creation for insurers

Digital Health Ecosystem

Digitization and automation driven by newer data based technologies are changing the traditional landscape of many industries. In healthcare, a data intensive industry, technology start-ups offering new products and services are creating newer opportunities for industry incumbents to solve long-standing problems and also meet the expectations of tech-savvy, new-age customers.

Digital Therapeutics – A Potential Game Changer in Value Based Drug Purchasing agreements

Value based drug purchasing

Value based drug purchasing model, to be implemented in USA in 2022, between payers, states and drug manufacturers where a drug will have multiple price points based on evidence based outcomes eg. reduced hospitalizations, reduced check ups etc. that will help private payers & states to pay based on a drug’s outcome and not a flat fee, thus saving a lot of capital.

Accelerating a seamless integration of digital health into traditional health insurance with DTx-Insurance collaboration

DTx-Insurance Partnerships

Availability of real-time and reliable health data from digital health tools, resolve of governments to combat non-communicable diseases and willingness of members to share health data in lieu of benefits such as a reduced premium is a perfect opportunity for insurers to enter into innovative digital health partnerships and move from being merely a payer of healthcare to partners in good health.

Digital disease management program – A responsive approach to manage chronic diseases during a pandemic

Disease Management Programmes

With the emergence of the COVID-19 pandemic that spread globally at an accelerated pace, healthcare resources at all levels were shifted away from the management and prevention of chronic diseases to contain the outbreak. Prolonged lock-downs have led to reduced access to healthcare, a sudden drop in the referrals to physicians, and a reduction in the hospitalization of patients for treatment of conditions other than the COVID-19 infection. Reports suggest a partial or complete disruption of services for chronic patients across many countries worldwide. Options for community-based support and care for such patients are limited, thereby leading to a serious concern about the effect of the pandemic on the long-term clinical outcomes of patients with chronic diseases.